Skip to content

Validating genomic biomarkers as risk markers for incidence, non-response and recurrence in depression - EDSP Study

Validating genomic biomarkers as risk markers for incidence, non-response and recurrence in depression - EDSP Study - OptiMD-SP4 EpiFam

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00009820
Enrollment
100
Registered
2016-12-14
Start date
2016-12-08
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32 F33

Interventions

Group 1: Family study investigating the inheritance of epigenetic modifications (DNA methylation) in CpG-rich regions within candidate genes (ABCB1, FKBP5, P2RX4, P2RX5) between children and adolescen
further, methylation rate in CpG-rich gene regions will be examined. Genetically and epigenetically inherited information will be compared between case and control families.

Sponsors

Max-Planck-Institut für Psychiatrie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 17 Years

Inclusion criteria

Inclusion criteria: Children and adolescents of both sexes aged 3 to 17 years, balanced in age and sex distribution between cases and controls; study consent of at least one parent or guardian of the study participant as well as oral and / or written consent of the minor study participant.

Exclusion criteria

Exclusion criteria: Pervasive developmental disorder in study participants (ICD10 F84)

Design outcomes

Primary

MeasureTime frame
Association of methylation rates between child and mother or father separately for families with and without maternal depression. The objective is to identify those genetic loci that allow the strongest separation of both groups of families. The analysis is focussed on DNA methylation in CpG-rich regions of the genes ABCB1, FKBP5, P2RX4 and P2RX7.

Secondary

MeasureTime frame
Allelci transmission rates of the candidate genes ABCB1, FKBP5, P2RX4 and P2RX7 from parents to child separately for families with and without maternal depression.

Countries

Germany

Contacts

Public ContactMarcus Ising

Max-Planck-Institut für Psychiatrie

ising@psych.mpg.de089 30622-1

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026